- severity of hypokalemia
- presence of associated conditions
- presence or absence of signs and symptoms
- expectation of continued losses.
Summary
Library
Citations
Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011 Feb;7(2):75-84.[Abstract]
Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018 Apr;7(4):R135-46.[Abstract][Full Text]
Greenlee M, Wingo CS, McDonough AA, et al. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med. 2009 May 5;150(9):619-25.[Abstract]
1. Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011 Feb;7(2):75-84.[Abstract]
2. Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018 Apr;7(4):R135-46.[Abstract][Full Text]
3. Schrier RW, ed. Renal and electrolyte disorders, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
4. Liu T, Nagami GT, Everett ML, et al. Very low calorie diets and hypokalaemia: the importance of ammonium excretion. Nephrol Dial Transplant. 2005 Mar;20(3):642-6.[Abstract][Full Text]
5. Clausen T, Flatman JA. Effect of insulin and epinephrine on Na+-K+-ATPase and glucose transport in soleus muscle. Am J Physiol. 1987 Apr;252(4 Pt 1):E492-9.[Abstract]
6. Shannon M, Lovejoy FH. Hypokalemia after theophylline intoxication. The effects of acute vs chronic poisoning. Arch Intern Med. 1989 Dec;149(12):2725-9.[Abstract]
7. Morgan DB, Young RM. Acute transient hypokalemia: a new interpretation of a common event. Lancet. 1982 Oct 2;2(8301):751-2.[Abstract]
8. Adrogue HJ, Lederer ED, Suki WN, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986 May;65(3):163-72.[Abstract]
9. Fontaine B, Lapie P, Plassart E, et al. Periodic paralysis and voltage-gated ion channels. Kidney Int. 1996 Jan;49(1):9-18.[Abstract][Full Text]
10. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999 Mar 22;159(6):601-6.[Abstract][Full Text]
11. Kung AW. Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006 Jul;91(7):2490-5.[Abstract][Full Text]
12. Viens P, Thyss A, Garnier G, et al. GM-CSF treatment and hypokalemia. Ann Intern Med. 1989 Aug 1;111(3):263.[Abstract]
13. Jameson JL, Fauci AS, Kasper DL, et al. Harrison's principles of internal medicine. 21st rev ed. New York: McGraw-Hill Education; 2022.
14. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood. 2008 Sep 15;112(6):2214-21.[Abstract][Full Text]
15. Ek J, Magnus EM. Plasma and red blood cell folate in breastfed infants. Acta Paediatr Scand. 1979 Mar;68(2):239-43.[Abstract]
16. Clemessy JL, Favier C, Borron SW, et al. Hypokalaemia related to acute chloroquine ingestion. Lancet. 1995 Sep 30;346(8979):877-80.[Abstract]
17. Buse S, Blancher M, Viglino D, et al. The impact of hypothermia on serum potassium concentration: a systematic review. Resuscitation. 2017 Sep;118:35-42.[Abstract]
18. Ravipati P, Murray S, Yannopoulos D, et al. Impact of AKI in patients with out-of-hospital cardiac arrest managed with VA ECMO. Kidney360. 2021 Nov 25;2(11):1827-30.[Abstract][Full Text]
19. Older J, Older P, Colker J, et al. Secretory villous adenomas that cause depletion syndromes. Arch Intern Med. 1999 Apr 26;159(8):879-80.[Abstract]
20. Agarwal R, Afzalpurkar R, Fordtran JS. Pathophysiology of potassium absorption and secretion by the human intestine. Gastroenterology. 1994 Aug;107(2):548-71.[Abstract]
21. Curran MP, Plosker GL. Oral sodium phosphate solution: a review of its use as a colorectal cleanser. Drugs. 2004;64(15):1697-714.[Abstract]
22. Quinkler M, Stewart PM. Hypertension and the cortisol-cortisone shuttle. J Clin Endocrinol Metab. 2003 Jun;88(6):2384-92.[Abstract]
23. Pepin J, Shields C. Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract. 2012 Feb;14(2):1-17.[Abstract]
24. Greenlee M, Wingo CS, McDonough AA, et al. Narrative review: evolving concepts in potassium homeostasis and hypokalemia. Ann Intern Med. 2009 May 5;150(9):619-25.[Abstract]
25. Adamidis A, Cantas-Orsdemir S, Tsirka A, et al. Apparent mineralocorticoid excess in the pediatric population: report of a novel pathogenic variant of the 11beta-HSD2 gene and systematic review of the literature. Pediatr Endocrinol Rev. 2019 Mar;16(3):335-58.[Abstract]
26. Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 Jan;97(1):42-61.[Abstract][Full Text]
27. Fan P, Lu YT, Yang KQ, et al. Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia. Endocrine. 2020 Dec;70(3):607-15.[Abstract][Full Text]
28. McHugh J, Nagabathula R, Kyithar MP. A life-threatening case of pseudo-aldosteronism secondary to excessive liquorice ingestion. BMC Endocr Disord. 2021 Aug 6;21(1):158.[Abstract][Full Text]
29. Perazella MA, Eisen RN, Frederick WG, et al. Renal failure and severe hypokalemia associated with acute myelomonocytic leukemia. Am J Kidney Dis. 1993 Sep;22(3):462-7.[Abstract]
30. Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 Jan;91(1):24-33.[Abstract][Full Text]
31. Fulchiero R, Seo-Mayer P. Bartter syndrome and Gitelman syndrome. Pediatr Clin North Am. 2019 Feb;66(1):121-34.[Abstract][Full Text]
32. Konrad M, Nijenhuis T, Ariceta G, et al. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders. Kidney Int. 2021 Feb;99(2):324-35.[Abstract][Full Text]
33. Mohr JA, Clark RM, Waack TC, et al. Nafcillin-associated hypokalemia. JAMA. 1979 Aug 10;242(6):544.[Abstract]
34. Carlisle EJ, Donnelly SM, Vasuvattakul S, et al. Glue-sniffing and distal renal tubular acidosis: sticking to the facts. J Am Soc Nephrol. 1991 Feb;1(8):1019-27.[Abstract][Full Text]
35. Carlisle EJ, Donnelly SM, Ethier JH, et al. Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int. 1991 Jun;39(6):1206-12.[Abstract][Full Text]
36. Douglas JB, Healy JK. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med. 1969 Jan;46(1):154-62.[Abstract]
37. Whang R, Whang DD, Ryan MP. Refractory potassium depletion. A consequence of magnesium deficiency. Arch Intern Med. 1992 Jan;152(1):40-5.[Abstract]
38. US Department of Health and Human Services. National Institutes of Health. Magnesium: fact sheet for health professionals. Jan 2026 [internet publication].[Full Text]
39. Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007 Oct;18(10):2649-52.[Abstract]
40. Hariprasad MK, Eisinger RP, Nadler IM, et al. Hyponatremia in psychogenic polydipsia. Arch Intern Med. 1980 Dec;140(12):1639-42.[Abstract]
41. Godek SF, Godek JJ, Bartolozzi AR. Hydration status in college football players during consecutive days of twice-a-day preseason practices. Am J Sports Med. 2005 Jun;33(6):843-51.[Abstract]
42. Dave S, Honney S, Raymond J, et al. An unusual presentation of cystic fibrosis in an adult. Am J Kidney Dis. 2005 Mar;45(3):e41-4.[Abstract]
43. Elisaf M, Liberopoulos E, Bairaktari E, et al. Hypokalaemia in alcoholic patients. Drug Alcohol Rev. 2002 Mar;21(1):73-6.[Abstract][Full Text]
44. Rostand SG. Profound hypokalemia in continuous ambulatory peritoneal dialysis. Arch Intern Med. 1983 Feb;143(2):377-8.[Abstract]
45. Córdoba JP, Larrarte C, Medina MC. Experience in therapeutic plasma exchange by membrane filtration at an academic center in Colombia: Registry of the first 500 sessions. J Clin Apher. 2015 Dec;30(6):347-52.[Abstract]
46. Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood. 1980 Dec;56(6):1055-9.[Abstract][Full Text]
47. Tetti M, Monticone S, Burrello J, et al. Liddle syndrome: review of the literature and description of a new case. Int J Mol Sci. 2018 Mar 11;19(3):812.[Abstract][Full Text]
48. Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic crises in adults with diabetes: a consensus report. Diabetes Care. 2024 Aug 1;47(8):1257-75.[Abstract][Full Text]
49. Helfant RH. Hypokalemia and arrhythmias. Am J Med. 1986 Apr 25;80(4a):13-22.[Abstract][Full Text]
50. Tse G, Li KHC, Cheung CKY, et al. Arrhythmogenic mechanisms in hypokalaemia: insights from pre-clinical models. Front Cardiovasc Med. 2021 Feb 3;8:620539.[Abstract][Full Text]
51. Tsuji H, Venditti FJ Jr, Evans JC, et al. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol. 1994 Aug 1;74(3):232-5.[Abstract]
52. Riemenschneider T, Bohle A. Morphologic aspects of low-potassium and low-sodium nephropathy. Clin Nephrol. 1983 Jun;19(6):271-9.[Abstract]
53. Chaudhry MA, Wayangankar S. Thyrotoxic periodic paralysis: a concise review of the literature. Curr Rheumatol Rev. 2016;12(3):190-4.[Abstract][Full Text]
54. Rose BD, Post TW. Clinical physiology of acid-base and electrolyte disorders. 5th rev ed. New York: McGraw-Hill; 2001.
55. Negrotto L, Barroso FA. Focal hypokalemic paralysis: report of 2 cases and review of the literature. J Clin Neuromuscul Dis. 2012 Sep;14(1):21-7.[Abstract]
56. Veltri KT, Mason C. Medication-induced hypokalemia. P T. 2015 Mar;40(3):185-90.[Abstract][Full Text]
57. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009 Jul;32(7):1335-43.[Abstract][Full Text]
58. Basok AB, Haviv YS, Rogachev B, et al. Renal tubular acidosis type I with prominent hypokalemia and nephrolithiasis as a presentation of Sjögren's/Systemic Lupus Erythematosus disease. Case Rep Nephrol Dial. 2021 May-Aug;11(2):247-53.[Abstract][Full Text]
59. Vasquez-Rios G, Westrich DJ Jr, Philip I, et al. Distal renal tubular acidosis and severe hypokalemia: a case report and review of the literature. J Med Case Rep. 2019 Apr 26;13(1):103.[Abstract][Full Text]
60. Barathidasan GS, Krishnamurthy S, Karunakar P, et al. Systemic lupus erythematosus complicated by a Gitelman-like syndrome in an 8-year-old girl. CEN Case Rep. 2020 May;9(2):129-32.[Abstract][Full Text]
61. Hamad A, Hussain ME, Elsanousi S, et al. Prevalence and management of hypokalemia in peritoneal dialysis patients in Qatar. Int J Nephrol. 2019 Dec 18;2019:1875358.[Abstract][Full Text]
62. Sterns RH, Cox M, Feig PU, et al. Internal potassium balance and the control of the plasma potassium concentration. Medicine (Baltimore). 1981 Sep;60(5):339-54.[Abstract]
63. Liamis G, Liberopoulos E, Barkas F, et al. Spurious electrolyte disorders: a diagnostic challenge for clinicians. Am J Nephrol. 2013;38(1):50-7.[Abstract][Full Text]
64. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-75.[Abstract][Full Text]
65. Schwartz WB, Relman AS. Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest. 1953 Mar;32(3):258-71.[Abstract][Full Text]
66. Oster JR, Materson BJ, Rogers AI. Laxative abuse syndrome. Am J Gastroenterol. 1980 Nov;74(5):451-8.[Abstract]
67. Ewe K, Karbach U. Factitious diarrhea. Clin Gastroenterol. 1986 Jul;15(3):723-40.[Abstract]
68. Carey RM. Diagnosing and managing primary aldosteronism in hypertensive patients: a case-based approach. Curr Cardiol Rep. 2016 Oct;18(10):97.[Abstract][Full Text]
69. Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016 May;101(5):1889-916.[Abstract][Full Text]
70. Sweetser S. Evaluating the patient with diarrhea: a case-based approach. Mayo Clin Proc. 2012 Jun;87(6):596-602.[Abstract][Full Text]
71. Castro-Rodríguez JA, Salazar-Lindo E, León-Barúa R. Differentiation of osmotic and secretory diarrhoea by stool carbohydrate and osmolar gap measurements. Arch Dis Child. 1997 Sep;77(3):201-5.[Abstract][Full Text]
72. National Institute for Health and Care Excellence. Eating disorders: recognition and treatment. Dec 2020 [internet publication].[Full Text]
73. Crone C, Fochtmann LJ, Attia E, et al. The American Psychiatric Association practice guideline for the treatment of patients with eating disorders. Am J Psychiatry. 2023 Feb 1;180(2):167-71.[Abstract][Full Text]
74. Jophlin LL, Singal AK, Bataller R, et al. ACG clinical guideline: alcohol-associated liver disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54.[Abstract][Full Text]
75. Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004 Mar;89(3):1045-50.[Abstract]
76. Torpy DJ, Mullen N, Ilias I, et al. Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci. 2002 Sep:970:134-44.[Abstract]
77. Mumford E, Unwin RJ, Walsh SB. Liquorice, Liddle, Bartter or Gitelman-how to differentiate? Nephrol Dial Transplant. 2019 Jan 1;34(1):38-9.[Abstract][Full Text]


